StockpollyBeta
Get App
Popularity #4,450
NTRB · NASDAQ · Biotechnology

Nutriband (NTRB)

Develops transdermal drug products centered on its AVERSA abuse-deterrent patch technology.

$6.85
After-hours close−0.10 (−1.44%)
At close$6.95(−10.55%)

In millions of USD, except per-share figures

In millionsQ3 FY23Oct 2023Q4 FY23Jan 2024Q1 FY24Apr 2024Q2 FY24Jul 2024Q3 FY24Oct 2024Q4 FY24Jan 2025Q1 FY25Apr 2025Q2 FY25Jul 2025Q3 FY25Oct 2025Q4 FY25Jan 2026Q1 FY26Apr 2026Q2 FY26Jul 2026
Revenue010011110000
Cost of revenue000000000000
Gross profit000000000000
212222224111
Research & development111110110000
Selling, general & administrative111112123111
Operating income−2−1−2−1−1−2−1−2−4−1−1−1
0−1000−4000000
Interest income000000000000
Interest expense000000000000
Other non-operating income010004000000
Income before tax−2−2−2−2−1−6−1−2−4−1−1−1
Net income from continuing operations−2−2−2−2−1−6−1−2−4−1−1−1
Net income−2−2−2−2−1−6−1−2−4−1−1−1
EPS, basic−$0.22−$0.23−$0.21−$0.15−$0.12−$0.51−$0.12−$2.12−$0.32−$0.08−$0.10−$0.07
EPS, diluted−$0.22−$0.23−$0.21−$0.15−$0.12−$0.51−$0.12−$2.12−$0.32−$0.08−$0.10−$0.07
Weighted average shares, basic889111111111112121212
Weighted average shares, diluted889111111111112121212
EBITDA−2−2−2−2−1−5−1−2−4−1−1−1
Depreciation & amortization000000000000
EBIT−2−2−2−2−1−6−1−2−4−1−1−1